174 related articles for article (PubMed ID: 7700506)
1. Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome.
Friedman TC; García-Borreguero D; Hardwick D; Akuete CN; Doppman JL; Dorn LD; Barker CN; Yanovski JA; Chrousos GP
Neuroendocrinology; 1994 Dec; 60(6):626-34. PubMed ID: 7700506
[TBL] [Abstract][Full Text] [Related]
2. Diurnal rhythm of plasma delta-sleep-inducing peptide in humans: evidence for positive correlation with body temperature and negative correlation with rapid eye movement and slow wave sleep.
Friedman TC; Garcia-Borreguero D; Hardwick D; Akuete CN; Stambuk MK; Dorn LD; Starkman MN; Loh YP; Chrousos GP
J Clin Endocrinol Metab; 1994 May; 78(5):1085-9. PubMed ID: 8175965
[TBL] [Abstract][Full Text] [Related]
3. Delta sleep-inducing-peptide-like immunoreactivity (DSIP-LI) and delta sleep in schizophrenic volunteers.
van Kammen DP; Widerlöv E; Neylan TC; Ekman R; Kelley ME; Mouton A; Peters JL
Sleep; 1992 Dec; 15(6):519-25. PubMed ID: 1475566
[TBL] [Abstract][Full Text] [Related]
4. High delta sleep-inducing peptide-like immunoreactivity in plasma in suicidal patients with major depressive disorder.
Westrin A; Ekman R; Träskman-Bendz L
Biol Psychiatry; 1998 May; 43(10):734-9. PubMed ID: 9606527
[TBL] [Abstract][Full Text] [Related]
5. Human plasma DSIP decreases at the initiation of sleep at different circadian times.
Seifritz E; Müller MJ; Schönenberger GA; Trachsel L; Hemmeter U; Hatzinger M; Ernst A; Moore P; Holsboer-Trachsler E
Peptides; 1995; 16(8):1475-81. PubMed ID: 8745061
[TBL] [Abstract][Full Text] [Related]
6. Delta sleep-inducing peptide in normal humans and in patients with sleep apnea and narcolepsy.
Vgontzas AN; Friedman TC; Chrousos GP; Bixler EO; Vela-Bueno A; Kales A
Peptides; 1995; 16(6):1153-6. PubMed ID: 8532601
[TBL] [Abstract][Full Text] [Related]
7. Presence of delta-sleep-inducing peptide-like material in human milk.
Graf MV; Hunter CA; Kastin AJ
J Clin Endocrinol Metab; 1984 Jul; 59(1):127-32. PubMed ID: 6547144
[TBL] [Abstract][Full Text] [Related]
8. Delta sleep-inducing peptide response to human corticotropin-releasing hormone (CRH) in major depressive disorder. Comparison with CRH-induced corticotropin and cortisol secretion.
Lesch KP; Widerlöv E; Ekman R; Laux G; Schulte HM; Pfüller H; Beckmann H
Biol Psychiatry; 1988 Jun; 24(2):162-72. PubMed ID: 2839244
[TBL] [Abstract][Full Text] [Related]
9. Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease.
Ernst A; Cramer H; Strubel D; Kuntzmann F; Schoenenberger GA
J Neurol; 1987 Oct; 235(1):16-21. PubMed ID: 2448424
[TBL] [Abstract][Full Text] [Related]
10. Delta-sleep-inducing peptide (DSIP) inhibited CRF-induced ACTH secretion from rat anterior pituitary gland in vitro.
Okajima T; Hertting G
Horm Metab Res; 1986 Jul; 18(7):497-9. PubMed ID: 3017833
[TBL] [Abstract][Full Text] [Related]
11. Different effects of delta-sleep-inducing peptide on arginine-vasopressin and ACTH secretion in normal men.
Chiodera P; Volpi R; Capretti L; Giacalone G; Caffarri G; Davoli C; Nigro E; Coiro V
Horm Res; 1994; 42(6):267-72. PubMed ID: 7698722
[TBL] [Abstract][Full Text] [Related]
12. Characterization, properties and multivariate functions of delta-sleep-inducing peptide (DSIP).
Schoenenberger GA
Eur Neurol; 1984; 23(5):321-45. PubMed ID: 6548966
[TBL] [Abstract][Full Text] [Related]
13. Effects of DSIP on narcolepsy.
Schneider-Helmert D
Eur Neurol; 1984; 23(5):353-7. PubMed ID: 6548968
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of corticotropin-releasing hormone in the inferior petrosal sinuses of healthy volunteers, patients with Cushing's syndrome, and patients with pseudo-Cushing states.
Yanovski JA; Nieman LK; Doppman JL; Chrousos GP; Wilder RL; Gold PW; Kalogeras KT
J Clin Endocrinol Metab; 1998 May; 83(5):1485-8. PubMed ID: 9589643
[TBL] [Abstract][Full Text] [Related]
15. The effects of delta-sleep-inducing peptide (DSIP) on wakefulness and sleep patterns in the cat.
Susić V; Masirević G; Totić S
Brain Res; 1987 Jun; 414(2):262-70. PubMed ID: 3620931
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma levels of opioid peptides and delta sleep-inducing peptide but not of corticotropin-releasing hormone in patients receiving chronic hemodialysis.
Hegbrant J; Thysell H; Ekman R
Blood Purif; 1991; 9(4):188-94. PubMed ID: 1667974
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive delta sleep-inducing peptide secretion from mouse dissociated, anterior pituitary cells: regulation by corticotropin-releasing factor and arginine vasopressin.
Bjartell A; Castro MG; Ekman R; Sundler F; Widerlöv E; Loh YP
Neuroendocrinology; 1989 Nov; 50(5):564-9. PubMed ID: 2558325
[TBL] [Abstract][Full Text] [Related]
18. Reduced sleep in cats after intraperitoneal injection of delta-sleep-inducing peptide (DSIP).
Sommerfelt L
Neurosci Lett; 1985 Jul; 58(1):73-7. PubMed ID: 3840239
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactive delta sleep-inducing peptide in the rat hypothalamus, pituitary and adrenal gland: effects of adrenalectomy.
Bjartell A; Sundler F; Ekman R
Horm Res; 1991; 36(1-2):52-62. PubMed ID: 1814802
[TBL] [Abstract][Full Text] [Related]
20. Delta-sleep-inducing peptide reduces CRF-induced corticosterone release.
Graf MV; Kastin AJ; Coy DH; Fischman AJ
Neuroendocrinology; 1985 Oct; 41(4):353-6. PubMed ID: 2995861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
